Klona Biotech
Klona Biotech specializes in the development of advanced bioprinting platforms to engineer fibrous, mechanically robust human tissue implants. Focusing initially on tendon and ligament repair, the company integrates expertise in material science, mechanical engineering, tissue engineering, and computational software to create scalable, regenerative, and customizable medical implants. The technology aims to replicate native tissue structure and mechanics, addressing current limitations in reconstructive procedures and donor tissue supply.
Industries
N/A
Products
Implant with fibrous architecture and mechanical properties designed to match native human tendons, produced without donor tissue and rapidly adaptable to other ligaments.
Integrated hardware and software platform designed to bioprint mechanically robust, fibrous tissues suitable for diverse implant applications.
Implant with fibrous architecture and mechanical properties designed to match native human tendons, produced without donor tissue and rapidly adaptable to other ligaments.
Integrated hardware and software platform designed to bioprint mechanically robust, fibrous tissues suitable for diverse implant applications.
Expertise Areas
- Tissue engineering
- 3D bioprinting
- Mechanical engineering for biomedical devices
- Material science for medical implants
Key Technologies
- Collagen-based biomaterials
- 3D bioprinting
- Custom slicer software for bioprinting
- Structure-mimetic implant design